Nexgard Spectra 19 mg / 4 mg Chewable Tablets for Dogs >3.5–7.5 kg

• Target species: Dogs
• Active substances: Afoxolaner, Milbemycin Oxime (A3 and A4)
• Pharmaceutical form: Chewable tablet
• Therapeutic group: Endectocide
• Authorisation route: National
• Legal category: POM-V
• Controlled drug status: Not a controlled drug
• Marketing Authorisation holder: Boehringer Ingelheim Vetmedica Gmbh
• Distributors: <span>Boehringer Ingelheim Vetmedica GmbH</span>
• Territory: Great Britain
• SPC: https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_2258287.PDF
• UKPAR: